离子通道贩运对心力衰竭的影响
Jean-Baptiste Reisqs1, Yongxia Sarah Qu1,2, Mohamed Boutjdir1,3,4
1Cardiovascular Research Program, VA New York Harbor Healthcare System, New York, NY, United States.
Frontiers in cardiovascular medicine
|February 29, 2024
概括
心力衰竭 (HF) 涉及离子通道功能障碍,特别是影响和电流,导致心律不整. 了解离子通道贩运为HF治疗提供了新的治疗途径.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 电子生理学 电子生理学
背景情况:
- 心力衰竭 (HF) 是一个不断增长的全球流行病,影响着数以百万计的人,并导致显著的死亡率和发病率.
- 目前的高频疗法提高了生存率,但无法阻止发病率的上升,因此需要对潜在机制有更深入的了解.
- 心律失常是高血压的严重并发症,源于心肌细胞的电生理学变化.
研究的目的:
- 在心力衰竭的背景下,审查了解离子通道贩运的最新进展.
- 强调离子通道贩运缺陷在心肌细胞电生理学和心律失常发育中的作用.
- 探索针对离子通道贩运新型高频疗法的潜力.
主要方法:
- 文献综述侧重于心力衰竭中的离子通道贩运机制.
- 对影响离子通道功能和组织的分子和细胞变化的分析.
- 对离子通道贩运和心脏电生理学之间的关系进行当前研究的综合.
主要成果:
- 离子通道运输中的缺陷,包括和电流的改变,都与高频相关的心律失常有关.
- 变体,微管变化和定蛋白质干扰等机制会破坏离子通道的定位和功能.
- 功能障碍的离子通道贩运显著改变心肌细胞电生理学,导致HF病理生理学.
结论:
- 离子通道贩运是心肌细胞电生理学的关键决定因素,也是导致心力衰竭的关键因素.
- 了解这些贩运机制为开发HF的创新治疗策略提供了基础.
- 准离子通道贩运途径可能提供一种新的方法来管理HF及其相关的心律失常.
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure Drugs: Inotropic Agents
586
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
586
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
429
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
429
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
Heart Failure Drugs: Diuretics
375
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
375


